--- title: "Eaton, AMD, SpaceX And A Health Care Stock: CNBC’s ‘Final Trades’" type: "News" locale: "en" url: "https://longbridge.com/en/news/300571463.md" description: "CNBC traders highlighted four stocks: Eaton, SpaceX, AbbVie, and AMD. Eaton was selected due to Wells Fargo's Overweight rating; SpaceX for its Starship orbital launch; AbbVie following FDA approval of its Parkinson's drug Juvmo; and AMD based on a StoneX Buy recommendation. The segment also noted recent price movements for these equities." datetime: "2026-09-30T12:07:15.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/300571463.md) - [en](https://longbridge.com/en/news/300571463.md) - [zh-HK](https://longbridge.com/zh-HK/news/300571463.md) generator: "portal-rs" --- # Eaton, AMD, SpaceX And A Health Care Stock: CNBC’s ‘Final Trades’ On CNBC’s “Halftime Report Final Trades,” **Joseph M. Terranova**, senior managing director for Virtus Investment Partners, picked **Eaton Corporation plc** (NYSE:ETN). Supporting his choice, Wells Fargo analyst Stephen Tusa initiated coverage on Eaton on Sept. 25 with an Overweight rating and a price target of $503. **Stephanie Link**, chief investment strategist, head of investment solutions and equity portfolio manager at Hightower Advisors, said **Space Exploration Technologies Corp.** (NASDAQ:SPCX) is still down 26% from its highs. In recent news, SpaceX announced that its launch vehicle Starship (designed to carry over 100 metric tons) took flight on Monday and reached orbit on Flight 14. *Don’t forget to check out our premarket coverage here* **Jason Snipe**, founder and chief investment officer of Odyssey Capital Advisors, named **AbbVie Inc.** (NYSE:ABBV) as his final trade. On Friday, the U.S. Food and Drug Administration (FDA) approved AbbVie’s Juvmo (tavapadon) tablets as the first and only selective D1/D5 receptor agonist for adults with Parkinson’s disease. **Joshua Brown**, co-founder and CEO of Ritholtz Wealth Management, recommended **Advanced Micro Devices, Inc.** (NASDAQ:AMD). Supporting his view, StoneX analyst Cody Acree reiterated a Buy on Advanced Micro Devices on Tuesday and maintained a $685 price target. ## **Price Action** - Eaton shares gained 0.4% to close at $433.27 on Tuesday. - SpaceX shares rose 2.6% to settle at $149.24 on Tuesday. - AbbVie shares fell 1.1% to close at $263.29 during the session. - AMD shares slipped 0.1% to settle at $607.57. **See More: Top Value Stocks** *Photo via Shutterstock* ### Related Stocks - [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md) - [AMD.US](https://longbridge.com/en/quote/AMD.US.md) - [ETN.US](https://longbridge.com/en/quote/ETN.US.md) - [SPCX.US](https://longbridge.com/en/quote/SPCX.US.md) - [AMDC.US](https://longbridge.com/en/quote/AMDC.US.md) - [AMDD.US](https://longbridge.com/en/quote/AMDD.US.md) - [AMDG.US](https://longbridge.com/en/quote/AMDG.US.md) - [AMDL.US](https://longbridge.com/en/quote/AMDL.US.md) - [AMDS.US](https://longbridge.com/en/quote/AMDS.US.md) - [AMDU.US](https://longbridge.com/en/quote/AMDU.US.md) - [AMDW.US](https://longbridge.com/en/quote/AMDW.US.md) - [AMDY.US](https://longbridge.com/en/quote/AMDY.US.md) - [AMUU.US](https://longbridge.com/en/quote/AMUU.US.md) - [AMYY.US](https://longbridge.com/en/quote/AMYY.US.md) - [DAMD.US](https://longbridge.com/en/quote/DAMD.US.md) - [DSPC.US](https://longbridge.com/en/quote/DSPC.US.md) - [LOFF.US](https://longbridge.com/en/quote/LOFF.US.md) - [SNK.US](https://longbridge.com/en/quote/SNK.US.md) - [SPAL.US](https://longbridge.com/en/quote/SPAL.US.md) - [SPCF.US](https://longbridge.com/en/quote/SPCF.US.md) - [SPCG.US](https://longbridge.com/en/quote/SPCG.US.md) - [SPCH.US](https://longbridge.com/en/quote/SPCH.US.md) - [SPCM.US](https://longbridge.com/en/quote/SPCM.US.md) - [SPCU.US](https://longbridge.com/en/quote/SPCU.US.md) - [SSPC.US](https://longbridge.com/en/quote/SSPC.US.md) - [YSPC.US](https://longbridge.com/en/quote/YSPC.US.md) ## Related News & Research - [Starship milestone lifts SpaceX stock. This analyst sees 40% upside.](https://longbridge.com/en/news/300449149.md) - [ARK's Winton says each Starship launch could add $700 million a year](https://longbridge.com/en/news/300832406.md) - [SpaceX’s debut quarter fails to lift off: Short seller Chanos flags Starship forecast cut — but Wall Street still sees big upside](https://longbridge.com/en/news/300661717.md) - [SpaceX Stock Forecast: Valuation Is Hard to Justify, Says Top Investor](https://longbridge.com/en/news/300356131.md) - [SpaceX's third quarter just ended. Here are the 3 numbers that matter most for the stock.](https://longbridge.com/en/news/300835258.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**